MedPath

A study about feeling of fatigue reduction effect of food containing algae

Not Applicable
Conditions
Healthy adults
Registration Number
JPRN-UMIN000036296
Lead Sponsor
CPCC Company Limited
Brief Summary

A significant reduction in feeling of physical fatigue was confirmed in the test food intake group.

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete: follow-up complete
Sex
All
Target Recruitment
200
Inclusion Criteria

Not provided

Exclusion Criteria

1) Subjects who have previous and/or current medical history of serious disease (e.g., heart function, blood vessel, liver function, kidney function, pulmonary function, endocrine function, function of digestive organ and/or metabolism). 2) Subjects who have been diagnosed chronic fatigue syndrome, or subjects who are decided having severe fatigue such as idiopathic chronic fatigue by investigator and/or sub-investigator. 3) Subjects who are visiting hospital due to chronic disease. 4) Subjects who have psychiatric disease such as depression and/or schizophrenia. 5) Subjects who have impairment of sleep which need medical treatment. 6) Subjects who are likely to cause allergies against test food especially algae and/or seaweeds. 7) Subjects who constantly use oral medicines and/or quasi-drug having the effect of recovering from fatigue or the effect of supplementation when physical fatigue. 8) Subjects who constantly use food with functional claim about feeling of fatigue. 9) Subjects who excessive alcohol intake. 10) Subjects their BMI is less than 17 kg/m2 or equal and more than 30 kg/m2. 11) Subjects who are participating the other clinical tests. Subjects who participated within three month prior to the current study and/or who plan to participate the other clinical tests. 12) Subjects who donated over 200mL blood and/or blood components within the last one month to the current study. 13) Males who donated over 400mL blood and/or blood components within the last three month to the current study. 14) Females who donated over 400mL blood and/or blood components within the last four month to the current study. 15) Females who are pregnant or lactating, and females who could become pregnant or lactating during test period. 16) Others who have been determined ineligible by principal investigator or sub-investigator.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath